KYMR in the 13F filings
Kymera Therapeutics Inc · CUSIP 501575104
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 14 Nov 2025
- latest of these filings; the earliest 13 Nov 2025
- Managers listing it
- 6
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 4 listed it in both
- Shares listed
- 13,015,984
- combined, among listed positions
- Reported value
- $737m
- combined, at the quarter end
Among the 95 comparable managers: 2 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing KYMR in Q3 2025
6 of 6 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 5,195,691 | $294m | 0.05% | Trimmed | -176,370 | 14 Nov 2025 (the filing on sec.gov) |
| T. Rowe Price Associates Inc | 5,097,378 | $289m | under 0.1% | Trimmed | -1,761,824 | 14 Nov 2025 (the filing on sec.gov) |
| Capital Research Global Investors | 1,262,182 | $71m | under 0.1% | Held | 0 | 13 Nov 2025 (the filing on sec.gov) |
| Holocene Advisors LP | 840,333 | $48m | 0.11% | New | new | 14 Nov 2025 (the filing on sec.gov) |
| Two Sigma Advisers LP | 372,400 | $21m | under 0.1% | Added | n.a. | 14 Nov 2025 (the filing on sec.gov) |
| Woodline Partners LP | 248,000 | $14m | 0.07% | Trimmed | -250,111 | 14 Nov 2025 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Holocene Advisors LPnew position · 840,333 shares now+840,333
Reductions
- T. Rowe Price Associates Incexisting position · 5,097,378 shares now-1,761,824
- Woodline Partners LPexisting position · 248,000 shares now-250,111
- Wellington Management Group LLPexisting position · 5,195,691 shares now-176,370
New positions and exits
New (1)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2020 | 2 | $8.3m | n.a. | n.a. |
| Q4 2020 | 1 | $11m | n.a. | n.a. |
| Q2 2021 | 1 | $1.8m | n.a. | n.a. |
| Q3 2021 | 1 | $7.6m | n.a. | n.a. |
| Q4 2021 | 1 | $171m | n.a. | n.a. |
| Q1 2022 | 2 | $30m | n.a. | n.a. |
| Q2 2022 | 1 | $2.0m | n.a. | n.a. |
| Q3 2022 | 1 | $2.2m | n.a. | n.a. |
| Q4 2022 | 3 | $226m | n.a. | n.a. |
| Q1 2023 | 3 | $268m | n.a. | n.a. |
| Q2 2023 | 1 | $2.5m | n.a. | n.a. |
| Q3 2023 | 1 | $1.4m | n.a. | n.a. |
| Q4 2023 | 3 | $150m | 2 | 1 |
| Q1 2024 | 6 | $496m | 4 | 2 |
| Q2 2024 | 4 | $343m | 3 | 1 |
| Q3 2024 | 5 | $582m | 3 | 2 |
| Q4 2024 | 6 | $536m | 5 | 1 |
| Q1 2025 | 4 | $372m | 2 | 3 |
| Q2 2025 | 5 | $615m | 3 | 2 |
| Q3 2025 | 6 | $737m | 2 | 3 |
| Q4 2025 | 7 | $1.7bn | 15 | 12 |
| Q1 2026 | 8 | $2.1bn | 12 | 15 |
| Q2 2026 | 8 | $3.0bn | 12 | 13 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
KYMR and GILD →KYMR and AMGN →KYMR and ARGX →Choose a stock to compare with KYMR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own KYMR, latest filings →Back to the 13F Explorer →